Drugs Made In America Acquisition DMIIR
NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT

Drugs Made In America Acquisition (DMIIR) Total Liabilities (2024 - 2026)

Drugs Made In America Acquisition (DMIIR) posted quarterly Total Liabilities of $17.8 million for Q4 2025, up 6886.68% year-over-year from $254783.0 in Q4 2024, and down 2.07% quarter-over-quarter from $18.2 million in Q3 2025.

Analysis

Drugs Made In America Acquisition (DMIIR) Total Liabilities (2024 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has reported Total Liabilities for 2 consecutive years, with $17.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Liabilities rose 6886.68% year-over-year to $17.8 million; the TTM figure through Dec 2025 stood at $17.8 million (up 6886.68% YoY), while the FY2025 annual figure was $17.8 million, up 6886.68% from the prior year.
  • Total Liabilities declined to $17.8 million in Q4 2025 per DMIIR's latest filing, from $18.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $18.2 million in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Cluster Group Holdings 8.00 Bn 8.00 Bn - 76,013.00
2 Agriculture & Natural Solutions Acquisition 853.42 Mn 853.17 Mn - 34.24 Mn
3 K&F Growth Acquisition 836.15 Mn 836.15 Mn - 10.07 Mn
4 Armada Acquisition 666.54 Mn 666.49 Mn - 14.71 Mn
5 Pioneer Acquisition I 652.74 Mn 652.27 Mn - 12.34 Mn
6 Oxley Bridge Acquisition 652.11 Mn 652.11 Mn - 12.19 Mn
7 Titan Acquisition 651.43 Mn 941.85 Mn - 14.47 Mn
8 GSR IV Acquisition 622.22 Mn 622.22 Mn - 9.24 Mn
9 Launch One Acquisition 618.70 Mn 618.70 Mn - 13.08 Mn
10 Drugs Made In America Acquisition 5.10 Mn 5.10 Mn - 18.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.14 Mn
Dec 31, 2025 17.80 Mn
Sep 30, 2025 18.18 Mn
Dec 31, 2024 254,783.00